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Background: Anxiety disorders affect approximately 10% to 20% of young people, can be enduring if left
untreated, and have been associated with psychopathology in later life. Despite this, there is a paucity of empirical
research to assist clinicians in determining appropriate treatment options. We describe a protocol for a randomized
controlled trial in which we will examine the effectiveness of a group-based Acceptance and Commitment Therapy
program for children and adolescents with a primary diagnosis of anxiety disorder. For the adolescent participants
we will also evaluate the elements of the intervention that act as mechanisms for change.
Methods/design: We will recruit 150 young people (90 children and 60 adolescents) diagnosed with an anxiety
disorder and their parent or caregiver. After completion of baseline assessment, participants will be randomized to
one of three conditions (Acceptance and Commitment Therapy, Cognitive Behavior Therapy or waitlist control).
Those in the Acceptance and Commitment Therapy and Cognitive Behavior Therapy groups will receive 10 × 1.5
hour weekly group-therapy sessions using a manualized treatment program, in accordance with the relevant
therapy, to be delivered by psychologists. Controls will receive the Cognitive Behavior Therapy program after 10
weeks waitlisted. Repeated measures will be taken immediately post-therapy and at three months after therapy
cessation.
Discussion: To the best of our knowledge, this study will be the largest trial of Acceptance and Commitment
Therapy in the treatment of children and young people to date. It will provide comprehensive data on the use of
Acceptance and Commitment Therapy for anxiety disorders and will offer evidence for mechanisms involved in the
process of change. Furthermore, additional data will be obtained for the use of Cognitive Behavior Therapy in this
population and this research will illustrate the comparative effectiveness of these two interventions, which are
currently implemented widely in contemporary clinical practice. Anticipated difficulties for the trial are the
recruitment and retention of participants, particularly adolescents. To avert these concerns and maximize
recruitment, several strategies will be adopted to optimize referral rates as well as reduce participant drop-outs.
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With a prevalence rate of 10% to 20%, anxiety disorders
are the most common mental health concern affecting
children and adolescents [1,2]. Young people with anx-
iety are typically underrepresented in clinical research,
and anxiety in children is often minimized by health
professionals, potentially due to a common perception
that in this population anxiety is developmental, transi-
ent and innocuous [3,4]. Despite this, anxiety in child-
hood increases the likelihood of academic and social
skills difficulties as well as substance abuse, and is often
enduring if untreated [2]. Furthermore, a childhood his-
tory of anxiety is a common precursor to depression,
and has been found to predict anxiety and depression in
later life [5-7].
In a recent review of the best available evidence for
the treatment of psychological disorders, Cognitive Be-
havior Therapy (CBT) was found to be the first-line
evidence-based psychosocial intervention for anxiety
among adults and is currently the most empirically sup-
ported therapeutic approach for children and adoles-
cents [8]. In part, this is a consequence of insufficient
evidence for alternative interventions [8], rather than
findings indicating other treatments are unsuitable. In-
deed, the dearth of population-specific research in this
area is highlighted by the aforementioned review, which
found a complete absence of studies assessing the effi-
cacy of CBT in the treatment of panic disorder among
children and variable levels of evidence for its use in
other anxiety disorders in this population [8]. Further-
more, others have found that one in four children do
not benefit from CBT [9]. As such, it is important that
other interventions are developed and evaluated to ad-
dress this shortcoming.
Acceptance and Commitment Therapy (ACT) has
sparked increased interest among clinicians and re-
searchers in the last decade [10]. ACT considers the fun-
damental cause of psychopathology and human suffering
to be the interrelationships of cognition, language and
life circumstances that lead to decreased capacity to
modify or continue exhibiting behaviors that are in the
service of personal values [11]. ACT aims to increase
psychological flexibility; ‘the process of contacting the
present moment fully as a conscious human being and
persisting or changing behaviour in the service of chosen
values’ [12]. Whereas other therapies focus on altering
the content, frequency and form of private experience
(thoughts, feelings and sensations), ACT works to mod-
ify the function of internal experience - such as
supporting individuals to recognize thoughts for what
they are, simply thoughts and not necessarily the truth -
and thus reduce their bearing on behavior [13]. ACT fo-
cuses on assisting clients to live valued meaningful lives
[11]. To do this, six core therapeutic processes organizedin a ‘hexaflex’ model are employed, including ‘accept-
ance,’ ‘defusion,’ ‘values,’ ‘committed action,’ ‘the present
moment’ and ‘self-as-context’ [14]. These processes are
interrelated and support each other in increasing psy-
chological flexibility.
ACT has a growing empirical base demonstrating its
efficacy for an array of problems, including the treat-
ment of anxiety concerns among adults such as social
phobia [15,16], generalized anxiety disorder [17] and
mathematics anxiety [18]. Indeed, in the first known re-
view of published ACT controlled trials up to 2005, the
authors found ACT to be superior to control conditions,
waitlists and treatment as usual at both post-intervention
and at follow-up across a myriad of different problems
from psychosis to work stress [12]. Whilst evidence for
the use of ACT in adult populations with anxiety has
grown, there is currently a paucity of research examining
the efficacy of ACT in children and adolescents with anx-
iety. A literature search produced only one published
study, that being a case study [19]. However, preliminary
research evidence supports the use of ACT among
young people with other problems including depres-
sion [20], anorexia [21], chronic pain [22] and high risk
sexual behavior [23].
Research evidence has supported the use of mindful-
ness, one of the ACT core processes, in the treatment of
young people. Four studies have assessed the impact of
mindfulness-based stress reduction among children and/
or adolescents with anxiety and found it to be effective
in reducing anxious symptoms [24-27]. A review of these
studies has previously been conducted [28]. Although
these studies show some early support for the use of
ACT for the treatment of childhood problems including
anxiety, they are subject to several methodological issues -
small samples, a lack of either control group or random
assignment, few objective measures, potential biases from
recruited volunteers, reliance on self or non-blind parent
or teacher reports and employment of non-clinical sam-
ples, and/or the inclusion of only one component of the
ACT model (that is, mindfulness) - that limit their valid-
ity. More rigorous research is required to solidify the ef-
fectiveness of mindfulness in the treatment of child
anxiety disorders and to extend the research into other
ACT core processes.
Clinical research has typically focused on assessing the
efficacy of interventions. However, this approach does
not assist in the identification of the specific techniques
that are empirically effective or, conversely, those that
are harmful [14]. Identification of the mechanisms of ac-
tion within a specific treatment could support clinical
practice and enable interventions to be tailored to meet
individual client needs. It has been proposed that ACT
works by supporting increased acceptance of internal ex-
perience and reducing fusion with negative thoughts to
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psychological flexibility [12]. ACT studies have typically
focused on evaluation of the core processes of the
model, as described above, to examine the validity and
impact of each [12]. These studies have found support
for the roles of defusion [29] and acceptance [17,30],
and some support for the role of values and/or commit-
ted action [17] in reducing psychopathology. Ultimately,
this emerging research has led to the genesis of three
ACT mediational hypotheses, that psychological inflex-
ibility precedes suffering among clinical and non-clinical
populations; ACT increases psychological flexibility; and
psychological flexibility leads to enhanced well-being,
decreased clinical symptoms and increased value-based
activities [14]. However, these studies are preliminary
and subject to several methodological limitations includ-
ing measures that lack psychometric evaluation, the use
of purely self-report measures and the use of measures
that concentrate on a small number of core processes,
leaving other parts of the ACT model untested [31].
Thus, to build upon the current empirical literature in
this area, this randomized controlled trial design in-
cludes the investigation of mechanisms of change in ad-
olescents with anxiety.
In summary, preliminary investigations of ACT in the
treatment of adult anxiety have produced promising re-
sults. Other studies have also supported the use of mind-
fulness - one of the six ACT core processes - in the
treatment of childhood anxiety, which suggest that ap-
proaches employed within ACT appear to be suitable for
child populations. To the best of our knowledge, this will
be the first randomized controlled trial to examine the
effectiveness of ACT in young people with a diagnosed
anxiety disorder. Given the popularity and use of ACT
in clinical practice [10], it is imperative that this form of
intervention be empirically evaluated for its efficacy.
Thus, the aim of this research is to examine the effect-
iveness of a manualized ACT group-therapy program in
the treatment of anxiety disorders among children and
adolescents. It is hypothesized that ACT will be at least
as effective in the treatment of anxiety disorders in these
populations relative to a manualized CBT group-
therapy program, and that ACT will be more effective
in the treatment of anxiety disorders in this population
relative to the control condition at both immediate
post-treatment and at three-month follow-up on out-
come measures. The secondary aim of the trial con-
cerns the adolescent participants and is to identify the
mechanisms of change surrounding the intervention
that are critical to changes in outcome measures. It is
hypothesized that these will include decreased experi-
ential avoidance and cognitive fusion, as well as in-
creased emotional awareness, acceptance and valued
living.Methods
Study design
This is a prospective randomized controlled trial. It is a
three (group: two intervention and one control) by three
(time: pre-, immediate post- and three-month post-
treatment) repeated measures factorial design. The over-
all study design is illustrated in Figure 1.
Participants
Participants will be approximately 150 children (90
younger and 60 older children) aged 7 to 17 years with a
primary diagnosis of a Diagnostic and Statistical Manual
of Mental Disorders (DSM-IV) anxiety disorder. The
participants will be age-classified as ‘children’, aged 7 to
11 years, and ‘adolescents’, aged 12 to 17 years. Twelve
years of age was determined as the cut-off point to be
consistent with other research involving ACT as a treat-
ment for problems among adolescents [20].
Participants will be recruited via referrals to the De-
partment of Psychological Medicine, The Children’s
Hospital at Westmead (CHW), Sydney, NSW, Australia.
Referrals will be accepted from anyone, including health
professionals (general practitioners, psychologists, pedia-
tricians), educational providers, and self-referrals. Writ-
ten informed consent will be obtained from the parent
or caregiver of the children and from the child/adoles-
cent. Ethical approval was obtained for this study from
the Human Research Ethics Committee at CHW and at
The University of Newcastle.
The researchers predict that the majority of refer-
rals will come from school counselors, followed by
word of mouth, then via parents’ referral through the
CHW intake phone line. In terms of proportions, it is
expected that 60% to 70% of referrals will come from
school counselors. On the basis of recruitment efforts
to date and requests to intake phone line, the re-
searchers consider that the anticipated sample will be
achieved.
Inclusion criteria
1. Aged between 7 and 17 years
2. Criteria met for a primary diagnosis of a DSM-IV
anxiety disorder (including panic disorder and/or
agoraphobia, obsessive compulsive disorder, specific
phobia, social anxiety disorder or generalized anxiety
disorder)
3. Available and able to attend CHW for pre-treatment,
immediate post-treatment and three-month post-
treatment assessments as well as attending a
minimum of 80% of therapy sessions
4. Have a parent or caregiver who is willing to attend
and participate in the assessment as well as a
minimum of 80% of therapy sessions.
Referrals received at The Children’s Hospital at Westmead
Potential participants contacted via phone and brief screening pre-assessment conducted to determine suitability for baseline assessment
Baseline assessments completed at The Children’s Hospital at  Westmead 
Eligible participants subjected to randomisation
Acceptance and Commitment Therapy (ACT) Cognitive Behaviour Therapy (CBT) Control
10 x 1.5 hour weekly sessions of ACT 10 x 1.5 hour weekly sessions of CBT 10 weeks no treatment waitlist
Post-treatment assessments completed at The Children’s Hospital at Westmead 
10 x 1.5 hour weekly sessions of CBT3-month post-treatment assessments completed at The Children’s Hospital at Westmead 
Figure 1 Study design.
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1. Developmental or language delay, as reported by the
parent or caregiver
2. Non-English speaker
3. Complex mental health problems such as psychosis,
conduct disorder or active suicidality
4. Complex medical conditions with a high degree of
medical dependence that would prevent them from
being able to attend at least 80% of sessions
5. Attention deficit disorder with hyperactivity
(ADHD) that is not well controlled. In addition to
initial screening via parent and teacher reports as
well as by a physician, as appropriate, ADHD will be
assessed by clinicians according to DSM-IV criteria
during the initial assessment. It was determined that,
unless ADHD is sufficiently controlled, the group-
based 1.5 hour program is an unsuitable structure
for both the child with this identified concern as
well as other group members
6. Medicated with an anxiolytic or antidepressant for
less than two months. However, in the instance of a
participant experiencing a marked increase in
symptom severity across treatment, there may be a
need to consider pharmacotherapy. Participants willhave weekly contact with the researchers across the
course of the program and changes in functioning or
status will be monitored in an ongoing way. Where
a participant’s progress appears to be worsening, a
case-by-case consideration of the need for a
medical assessment for potential commencement
of pharmacotherapy will be undertaken. In
addition to this, the uptake of medication external
to that identified across the trial will also be
assessed at follow-up assessment. If a participant
does utilize medication of this kind throughout the
course of the study, they will be excluded from
data analysis.
7. Post-traumatic stress disorder (due to the potential
distress caused to other participants in the group
and the specialized treatment required for this
disorder)
8. Completed <70% of sessions or dropped out of
treatment - those who become lost to follow-up will
be placed in the intention-to-treat category.
Procedure
Initial assessment
Following referral, the caregivers of potential child and
adolescent participants will be briefly screened over the
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using a checklist developed for this study. Information
collected as part of this assessment will include psychi-
atric diagnoses and psychiatric symptoms - to identify
anxiety as the primary presenting problem and consider
differential diagnoses - as well as current and previous
treatment including medication (type, dosage, period of
pharmacological treatment) in accordance with the
aforementioned inclusion and exclusion criteria. If
deemed suitable at this point, they will be sent an infor-
mation pack about the study including consent forms,
and a battery of questionnaires to be completed by both
the child/adolescent and caregiver as part of the baseline
assessment. All assessment tools employed have demon-
strated reliability and validity (described in detail below).
To complete the baseline assessment the child/adolescent
and parent will attend CHW to undertake a face-to-face
diagnostic interview to determine the presence of an anx-
iety disorder using the Anxiety Disorders Interview Sched-
ule for DSM-IV [ADIS-IV] (Silverman & Albano, 1996).
ADIS-IV interviews of both parent/caregiver and child/
adolescent which will be conducted separately by psychol-
ogists trained in the administration of the instrument. All
interviews will be recorded for reliability purposes. The re-
searchers conducting baseline assessments will be blinded
to the treatment type to reduce potential.
Randomization
Following baseline assessment, eligible participants and
their caregivers will be randomized to one of three con-
ditions - ACT, CBT or a waitlist control group - for a
period of 10 weeks (described in detail below). Each
group will comprise up to eight children/adolescents as
well as their caregivers. The researchers involved in this
study are six registered psychologists, all trained in ACT
and CBT. This will be a block randomized controlled
trial, with the participant serving as the unit of
randomization. Randomization will be undertaken via a
publically available random assignment software applica-
tion, ‘Graphpad’ [www.graphpad.com/quickcalcs/].
Follow-up assessment
Follow-up repeated measures assessment will be com-
pleted immediately post-treatment - or after 10 weeks
for the control group - and three months post-treatment
for both intervention groups. Following completion of
the 10-week post assessment, the control group will
complete a program of 10 × 1.5 hour sessions of CBT.
Although it will not be possible to ensure the re-
searchers conducting post-intervention and follow-up
assessments will be blinded to the treatment type, to re-
duce potential bias these interviews will be recorded for
reliability purposes and reviewed and re-rated by an inde-
pendent assessor - a psychologist within the Departmentof Psychological Medicine with training in the use of the
ADIS-IV - blind to the diagnosis obtained. Participants
will also be assessed on the uptake of pharmacotherapy
throughout the course of the trial at follow-up.Outcome measures
Primary outcome measures
Anxiety Disorders Interview Schedule (ADIS-IV) [32]. The
ADIS-IV is a structured diagnostic interview that assesses
for a range of DSM-IV disorders typically first diagnosed
in childhood or adolescence [33] from the perspective of
both child (ADIS-C) and parent (ADIS-P) [34]. The
ADIS-C and ADIS-P demonstrate good-to-excellent clin-
ician inter-rater agreement, diagnostic reliability and test-
retest reliability [35,36].
Multidimensional Anxiety Scale for Children (MASC)
[37]. The MASC is a 39-item self-report inventory of
anxiety symptoms. It assesses four factors of anxiety in-
cluding physiological symptoms, avoidance, social and
separation anxiety [34,38]. Research has shown the
MASC exhibits acceptable convergent and divergent val-
idity, moderate-to-strong internal reliability, and ad-
equate test-retest and discriminate validity [34,39,40].
Child Behavior Checklist - Parent Form (CBCL) [41].
The CBCL is a widely utilized standardized measure of
children’s and adolescents’ (aged 5 to 18 years) emotional
and behavioral functioning as well as social competence
[42]. The social competence scales examine the child’s
adaptive functioning including their activities, and social
and school performance [42]. Behavioral and emotional
functioning is assessed by 118 items, which describe an
array of problems that children might experience [42,43].
Validity and reliability data were obtained in a sample of
over 5,000 children and were found to be moderate-to-
high and high, respectively [44].
For the primary aim of the trial, relating to efficacy of
the intervention, the primary outcome measures will be
whether the participant meets criteria for one or more
DSM-IV anxiety disorders and/or clinically significant
changes in severity scores on the ADIS-IV, CBCL or
MASC assessments. Clinically significant change will be
defined as a change in score that places the participant
within a different severity range on the relevant assess-
ment. For the ADIS-IV, this will be a shift in interfer-
ence ratings between ‘Very severe’ (8), ‘Severe’ (6 to 7),
‘Moderate’ (4 to 5), ‘Mild’ (1 to 3) or ‘Absent’ (0) ranges
[45]. For the CBCL, this will be represented by a change
in t-scores among the ‘Clinical’ (≥69); ‘Borderline clin-
ical’ (56 to 69) and ‘Normal’ (≤55) ranges [41]. For the
MASC, in accordance with March [37], this will be a
shift in t-score between the ‘Severe’ (≥70); ‘Moderate’
(56 to 69) and ‘Non-clinical’ (≤55) ranges. Secondary
outcome measures will include anxiety symptoms;
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efficacy (Table 1).
Secondary measures
Child Depression Inventory (CDI) [46]. The CDI is one of
the most widely utilized and cited diagnostic instruments
for depression in children [47,48]. It is a 27-item self-report
assessment, adapted from the Beck Depression Inventory
[48]. Research has found the CDI test-retest reliability to be
moderate range for clinical samples and adequate internal
consistency, concurrent validity [47] and discriminant val-
idity have been established [46].
Children’s Anxiety Life Interference Scale - Child Form
(CALIS-C) [49] - Adolescents only. The CALIS-C is a 10-
item self-report questionnaire about the impact of fears
and worries on an adolescent’s quality of life, self-
efficacy and well-being [49]. Reliability estimates were
found to be adequate; moderate-to-strong convergent
validity and discriminant validity have been observed
[49]. The CALIS-C also demonstrates sensitivity to
change [49].
McMaster Family Assessment Device (FAD) [50]. The
FAD is a 53-item inventory completed by caregivers on
the structure, organization and patterns of transactions
within families [50]. Six dimensions of family function-
ing are identified in the model including Problem Solv-
ing, Communication, Roles, Affective Responsiveness,
Affective Involvement and Behavioral Control [50].
Moderate-to-strong reliabilities have been obtained for
the FAD [50]. It also has established discriminant [50]
and concurrent validity [51].
Process measures – Adolescents only
Avoidance & Fusion Questionnaire - Youth (AFQ-Y) [52].
The AFQ-Y is a 17-item self-report measure of cogni-
tive fusion and experiential avoidance for children andTable 1 Primary and secondary outcome measures as






DSM-IV Anxiety disorder ADIS-IV




Depression symptoms CDI, CBCL
Quality of life and self-efficacy CALIS-C
Demographic factors FAD, age, sex
ADIS-IV, Anxiety Disorders Interview Schedule; CALIS-C, Children’s Anxiety Life
Interference Scale - Child Form; CBCL, Child Behavior Checklist - Parent Form;
CDI, Child Depression Inventory; DSM-IV, Diagnostic and Statistical Manual of
Mental Disorders; FAD, Family Assessment Device; MASC, Multidimensional
Anxiety Scale for Children.adolescents [52]. Confirmatory factor analysis has sup-
ported the hypothesized one-factor model of the AFQ-Y
and internal consistency reliability was also found to be
strong [52].
Child and Adolescent Mindfulness Measure (CAMM-20)
[53]. The CAMM-20 is a 20-item self-report question-
naire that focuses on internal and external awareness
as well as mindfulness [53]. Exploratory factor analysis
found support for a CAMM-20 two-factor model of
‘Observing’, noticing and attending to stimuli including
internal and external phenomena, and ‘Acting with Aware-
ness (AWA)’ including items that involve absolute focus
and engagement with activity in the present moment [53].
The internal consistency of both scales was in the moder-
ate range [53].
Positive and Negative Affect Schedule (PANAS-X) [54].
The PANAS-X is a 20-item measure of emotional ex-
perience across two scales, Positive Affect (PA) and
Negative Affect (NA) [55]. Respondents rate the extent
to which they have experienced an emotion over a pre-
scribed time [55]. Internal consistency reliabilities were
found to be in the moderate-to-high range across both
scales, and low correlations between the NA and PA
scales indicate good discriminant validity [54], with simi-
lar results obtained in a sample of adolescents [53]. The
PANAS-X demonstrates adequate construct validity and
high internal consistency [54].
Toronto Alexithymia Scale (TAS-20) [56]. The TAS-20
is a 20-item self-report inventory of the construct of
alexithymia and produces scores in three related do-
mains: difficulty identifying feelings, difficulty describing
feelings and externally-orientated thinking [57]. The
TAS-20 has been found to demonstrate adequate con-
vergent, discriminant and concurrent validity [58].
Valued Living Questionnaire (VLQ) [59]. The VLQ mea-
sures valued living or the degree to which an individual
accesses their chosen values in everyday life [59]. The
VLQ is comprised of two 10-item scales, where partici-
pants rate the importance of different domains of life -
family, intimate relationships, parenting, friendship, work,
education, recreation, spirituality, citizenship and physical
self-care - and subsequently rate the consistency with
which they have acted in accordance with their values in
the past week [59]. Wilson et al. [59] found the VLQ to
demonstrate adequate-to-good internal consistency across
domains.
For the secondary aim of the trial, relating to the mecha-
nisms for change, process outcome measures have been
developed for adolescents only and have been selected in
accordance with the domains hypothesized to be associ-
ated with treatment efficacy in line with results of previous
research (described above). As such, primary process out-
come measures include experiential avoidance, cognitive
fusion, acceptance and valued living (Table 2).
Table 2 Primary outcome measures as they relate to the
mechanism of change aim








AFQ-Y, Avoidance and Fusion Questionnaire - Youth; CAMM-20, Child and
Adolescent Mindfulness Measure; PANAS-X, Positive and Negative Affect
Schedule; TAS-20, Toronto Alexithymia Scale; VLQ, Valued
Living Questionnaire.
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Participants allocated to ACT or CBT groups will
complete a group-based therapy program of 10 × 1.5
hour sessions of the applicable treatment at CHW,
which will be provided at no cost. Up to eight children
or adolescents will be involved in each group program.
Treatment will be conducted by between two and four
psychologists, dependent upon final group numbers. All
psychologists involved in the delivery of the intervention
have been equally trained in both ACT and CBT, with
the exception of one who has advanced training in CBT
and intermediate training in ACT.
Caregivers will be involved concurrently in a “parent-
as-coach” manner. Across both programs, the treatment
will incorporate aspects that involve the participants and
caregivers working independently of one another, as well
as aspects that require working together. Both programs
will also require regular completion of between-session
practice tasks by both caregiver and the participant that
will be reviewed at the subsequent session.
Both ACT [60-62] and CBT [63-65] programs will be
based upon treatment manuals, tailored to the needs of
participants. Manuals have been developed for children,
adolescents, caregivers and therapists. Each program in-
corporates a series of psychological techniques consistent
with the therapeutic modality employed. However, there
are some commonalities across both interventions includ-
ing psychoeducation, skills training and exposure. Al-
though exposure to feared situations is a prominent
technique employed across both ACT and CBT, the ap-
proach differs across therapies. In CBT, the focus is on
challenging maladaptive thinking to enable performance
of the exposure behavior, whereas in ACT, children or ad-
olescents are encouraged to attempt to alter the relation-
ship they have with their anxiety by distancing themselves
from it and increasing their willingness to experience it.
CBT program - Cool Kids (ages 7 to 11 years) and Chilled®
(ages 12 to 17 years)
The CBT program will comprise the Cool Kids and
Chilled® Programs developed at the Centre for EmotionalHealth, Macquarie University [66]. The effectiveness of
Cool Kids and Chilled® in treating anxiety has been empir-
ically demonstrated [66]. Cool Kids and Chilled® assist
children and adolescents, respectively, to learn skills to
recognize their emotions and combat anxiety, encouraging
brave behavior and gradual engagement with feared situa-
tions. Because CBT is currently the most empirically sup-
ported therapeutic approach for children and adolescents
[8], it was determined to be the most stringent compari-
son condition to employ within this trial. The ‘worry wave’
section of the Cool Kids and Chilled® Programs will be
omitted for the purposes of this research as it was consid-
ered to have mindfulness components more consistent
with an ACT approach. This is a small component of the
overall program.ACT program - Cool Mind (ages 7 to 11 years) and
Mindchill (ages 12 to 17 years)
The Cool Mind for Kids and Mindchill programs have
been developed at CHW. They are both adaptations of
the Cool Kids and Chilled® programs and were designed
to conform to the overarching structure of these pro-
grams for comparison purposes. Cool Mind for Kids and
Mindchill were developed on the basis of ACT-consistent
protocols adapted from the Mindfulness-Based Cognitive
Therapy for Children protocol [2]; Acceptance and Com-
mitment Therapy Adapted for Children protocol [67],
MiCBT protocol [68], and ACT Mindfully Workshops
[69]. These programs incorporate all six ACT core thera-
peutic processes that target psychopathology including
Acceptance, Being Present/Mindfulness, Valued direc-
tions, Committed Action, Self-as-context and Cognitive
defusion. Children will learn skills to manage the distress
associated with anxious thoughts and feelings. For ex-
ample, whereas CBT attempts to dispute and modify un-
realistic thoughts, ACT supports children to identify their
values and behave in a value-consistent way. At the same
time acceptance of anxious thoughts and feelings that may
arise in the process of doing so is encouraged, as is learn-
ing to defuse these thoughts and feelings. While the con-
tent is similar for Cool Mind for Kids and Mindchill
programs, the language is simplified for the child program
and there is a greater focus on values for the adolescent
program. Table 3 provides a session-by-session outline of
the programs.Controls
The control group in the study will be a waitlist group,
also diagnosed with an anxiety disorder. Participants al-
located to this group will complete baseline assessments
and will receive CBT following a waiting list period of 10
weeks. This period was selected as it corresponds with
the 10 week program, allowing for comparative post
Table 3 Session-by-session overview of the Acceptance and Commitment Therapy programs, Cool Mind and Mindchill
Session Mindchill program (adolescents) Cool Mind for Kids program (children)
1 Introductions, group expectations and an emphasis on the
importance of practice tasks; psychoeducation on anxiety, values
and feelings; introduction to acceptance and mindfulness as
alternatives to ‘getting rid’ of unpleasant thoughts and feelings.
Practice tasks: Mindful smiling
Introductions, group rules, psychoeducation on anxiety, learning
about feelings, Feeling/worry scale, pink elephant and Chinese finger
trap exercises to introduce the futility of control and acceptance as
an alternative; introduction to mindfulness. Practice tasks: What I
think and feel, mindful smiling/breathing whilst waking up
2 Barriers to mindfulness practice, mindfulness of the breath, mindful
eating, choosing to live a valued life regardless of fear, mindful
movement, rewards, Practice tasks: Additional mindfulness practice
Mindfulness of the breath, mindful eating, thoughts/feelings and
control; anxiety and my body, psychoeducation on acceptance;
mindful movement. Practice tasks: Mindfulness of the breath,
mindfulness while lying down, mindfulness in everyday activities,
‘Me and My Body’ physiological aspects of anxiety
3 Mindful breathing; ‘milk, milk, milk’ exercise as introduction to
defusion; mindful thinking; acceptance versus tolerance of anxiety.
Practice tasks: Defusion and mindfulness exercises
Mindful breathing; ‘milk, milk, milk’ exercise as an introduction to
defusion; introduction to and practice of defusion strategies; mindful
thinking; introduction to rewards. Practice tasks: Defusion exercise,
mindfulness of the breath, mindfulness in everyday activities
4 Body scanning; creating a fears and worries list; mindful thinking
practice; introduction to stepladders (exposure) and first attempt to
create own exposure hierarchy. Practice tasks: Body scanning,
mindful thinking and working on personal stepladder
Body scanning; mindful thinking practice; creating a fears and
worries list; introduction to stepladders (exposure) and first attempt
to create own exposure hierarchy. Practice tasks: Daily body
scanning, mindful thinking worksheets, create first stepladder
5 Imaginal exposure using stepladders; experiential avoidance and
taking our worries with us through life; mindful thinking additional
practice; revising stepladders. Practice tasks: Mindfulness practice and
stepladders
Imaginal exposure using stepladders; experiential avoidance and
taking our worries with us through life; mindful thinking for big
worries; stepladders for big worries. Practice tasks: Body scanning,
mindful thinking and exposure
6 Mindfulness practice, leaves on a stream exercise; judging versus
describing, ‘unhooking’ from thoughts; letting go of negative self-
judgements, acceptance. Practice tasks: Stepladders
Mindfulness practice, leaves on a stream exercise; judging versus
describing, acceptance; working on stepladders for big worries.
Practice tasks: Mindfulness meditation, imaginal exposure practice
about the worst that can happen if he or she confronts the difficult
situation and work on stepladders
7 Body scanning additional practice; dealing with set-backs or getting
stuck; coping strategies; problem-solving skills building. Practice
tasks: Body scanning and imaginal exposure on stepladders
Body scanning additional practice; mindful touch; problem-solving
skills building; mindful thinking. Practice tasks: Mindfulness body
scanning, exposure (both imaginary and real life)
8 Mindfulness practice; assertive communication; in-session exposure
related to stepladders or fears and worries list; problem-solving any
set-backs. Practice tasks: Mindful thinking worksheets with
stepladders, seeking feedback for areas of self-doubt
Mindfulness practice; assertive communication; in-session exposure
related to stepladders or fears and worries list; problem-solving any
set-backs. Practice tasks: Mindfulness thinking, exposure in real life,
practicing problem-solving
9 Mindful breathing additional practice; coping with teasing and
bullying; external strategies to manage worries; review of progress
towards goals; additional in-session exposure. Practice tasks: Act on
one goal not yet achieved, family discussion of managing anxiety
and stress in everyday life
Mindful breathing additional practice; outsmarting bullies; review of
progress towards goals; additional in-session exposure. Practice tasks:
Practicing describing thoughts rather than judging, practicing
assertiveness, mindfulness activities, 10 minutes/day
10 Loving kindness meditation; reviewing goals; planning for the future;
dealing with set-backs and celebrating success
Friendly wishes meditation; reviewing goals; focus on values guiding
action; planning for the future; dealing with set-backs and
celebrating success
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Treatment fidelity
Across the group treatment period, all psychologists will
receive weekly group supervision. As the psychologists
involved in the delivery of the treatment are involved in
the delivery of both the ACT and CBT treatments, treat-
ment fidelity is an important consideration that will be
addressed via video-recording a subset of each 10 week
program. Video-recording will be conducted with the
consent of all participants and will be reviewed and ana-
lyzed by an independent assessor, for fidelity with the
identified treatment (ACT or CBT) in accordance with a
checklist designed for this study. The independentassessor will be a psychologist, with training in the
use of both ACT and CBT, within the Department of
Psychological Medicine who is not involved in the treat-
ment groups. Two independent assessors will be em-
ployed to ensure reliability of treatment fidelity ratings.
Feedback on the outcome of these reviews will be pro-
vided back to the research team and subsequently ex-
plored within weekly supervision. In line with the
protocol of Forman et al. [70], therapist allegiance to-
wards treatment will be assessed by having each psych-
ologist respond to the question ‘Which treatment do
you think leads to better outcomes, ACT or CBT?’.
Therapist allegiance will be examined as a variable of
interest in terms of any possible association with study
outcomes.
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A power analysis was conducted to determine the ap-
proximate sample size required to achieve an examination
of the effectiveness of a manualized ACT group-therapy
program, the most sensitive aim. At a power level of 0.8,
with an effect size (ES) of 0.6 to 0.7, it is estimated that a
minimum 30 participants in each group is required to de-
tect a significant difference between each of the three
groups. The employment of analysis of covariance and
mixed model statistical tests for pre versus post compari-
sons will also offer increased power to detect significant
differences. The estimated ES of 0.6 to 0.7 is based on the
results of three previous meta-analyses of ACT. In terms
of primary outcome measures, Hayes et al. [31] observed
that, compared to structured interventions, ACT was
superior after treatment (d = 0.48) and at follow-up
(d = 0.63). Ost [71] found that ACT was superior to
established treatments achieving a mean ES of 0.68. In
contrast, Powers et al. [72] found that, on primary out-
come measures, ACT achieved ES in the range g = 0.42 to
0.68 when ACT was compared with control or waitlist
conditions and g = 0.18 compared to established treat-
ments. The ES for the current study is estimated in
line with the higher-end ES results achieved across the
aforementioned meta-analyses. The rationale for this is
that these meta-analyses have incorporated studies for
a range of low-prevalence disorders - disorders that are
typically considered to be treatment resistant - whereas
the current study focuses only on anxiety, high prevalent
disorders, widely acknowledged to be more responsive
to treatment.
Statistical analysis
Data coding and analysis will be conducted using the
IBM SPSS Statistics v.21 software program. Primary out-
come measures will be examined both with intention-to-
treat analyses and analyses conducted on treatment
completers. For the efficacy hypotheses, paired t-tests
and linear mixed models will be used to investigate
changes in pre versus post primary and secondary out-
come measures. Statistical significance will be consid-
ered as P <0.05. The mixed model approach has been
selected as it allows for inter-participant and intra-
participant variance as well as the inclusion of partici-
pants with missing data, whilst maintaining power.
In accordance with the protocol of Forman et al. [70],
mechanism of change hypotheses will be examined using
correlation and independent t-tests to determine which
variables to include in a multivariate analysis of variance.
Post-hoc multiple comparisons (for example, Bonferroni
correction) will be performed to determine where sig-
nificant differences lie. Multivariate regression examin-
ing factors related to treatment success will also be
employed and will include examining any demographic(such as age, gender, family functioning) and clinical
(such as pre-scores, psychological flexibility) factors that
might be related to outcomes. Mediational analysis, a
regression-based approach, will be used to test hypoth-
eses about the mechanisms behind outcome, as this is a
powerful way of determining mechanisms by which an
effect operates rather than the existence of an effect
[73]. It allows for more than one mediator and adjusts
all paths for the potential influence of covariates not
proposed to be mediators in the model. Receiver operat-
ing curve plots of the true positive and false positive rate
for different possible cut-points of the regression test
will be conducted because receiver operating curves
convey information relating to the trade-off between
sensitivity and specificity, and maximize predictive value.
The coordinates of the receiver operating curve will be
used to determine the optimal cut-point for the test.
The full information maximum likelihood method will
be used to deal with missing data.
Discussion
Whilst research has found that ACT is supportive in the
treatment of anxiety in adult populations and has been
found to be effective in the treatment of children with
other concerns, there is a paucity of research examining
the effectiveness of ACT among children with anxiety.
To the best of the researchers knowledge, this study will
be the first randomized controlled trial examining the ef-
fectiveness of ACT in young people with a diagnosed
anxiety disorder. Conducted in a clinical practice con-
text, this research will assess psychological interventions
suitable for implementation in broader psychological set-
tings. If found to be effective, this trial will support the
development of ACT treatment protocols that could be
made available to clinicians for use in both public and
private contexts. It will offer the potential to provide an
evidence base to support alternative treatment for anx-
iety in young people, particularly for those who do not
benefit from standard treatments. This will allow for
greater flexibility in the tools clinicians can use, and
tailor treatment according to individual needs.
In terms of anticipated difficulties for the research, re-
cruitment and retention of participants (particularly ado-
lescents) has been identified as a potential caveat. A
number of factors have been identified may contribute
to this including the stringent inclusion and exclusion
criteria, requiring a primary diagnosis of anxiety disorder
and an absence of complex presentations such as
suicidality; availability and interest of adolescents and
caregivers to commit to attendance of at least 80% of
sessions; and other issues specific to the population to
be studied, such as School Certificate and Higher School
Certificate examinations. To avert this anticipated con-
cern, a proactive approach will be adopted to attempt to
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chological Medicine, CHW, and will include contacting
current and potential referrers - pediatricians, general
practitioners, psychiatrists, health professionals within
child and adolescent mental health, and private practi-
tioners – to inform them about the study. Direct referral
to community members will be encouraged among com-
pleters of the programs; school newsletter publications
and CHW’s Bandaged Bear Bulletin (distributed to all
hospital staff and affiliates) will be employed to detail
parents on the study; and physical advertisements will
be placed in waiting rooms within CHW.
Other approaches will focus on school counselors,
who often see adolescents with problems of anxiety, as
previous research has found that schools were beneficial
avenues for recruitment drives [74]. Methods of increas-
ing referral rates will also include presentations of the
research and inclusion criteria and peer networking
undertaken by the researchers at various professional de-
velopment courses as previous research with adolescents
found that informing key decision makers and commu-
nity sources in the early stages of the research were as-
sociated with better recruitment outcomes [74]. Another
approach being considered is conducting adolescent
groups at some of the high schools that have expressed
interest. This will, however, require parents to attend in
school time along with the students. Finally, other ap-
proaches will include cold calling and emailing to refer-
rer mailing lists.
Although some studies have found monetary incen-
tives facilitated increased recruitment and retention in
research with adolescents [74], this has not been ob-
served universally [75,76] and will not be feasible in the
current study. Instead, engagement in the research will
be supported by the provision of the treatment by regis-
tered psychologists experienced in the delivery of these
programs at no cost and ensuring expectations of partic-
ipants is communicated with clarity and consistency,
particularly in the early stages of recruitment. Retention
issues will also be addressed by enabling participants in
the intervention groups to complete a ‘catch-up’ session
the following week if they are unable to attend a session
with one of the treating psychologists and encourage-
ment of in-group socialization within the therapy to es-
tablish group cohesiveness. It is anticipated that these
approaches will be somewhat supportive in addressing
recruitment and retention issues in the current trial.
The researchers will publish outcomes of this trial in
peer-reviewed clinical journals. Findings will also be
disseminated at relevant conferences that would be
attended by practicing clinicians. Findings will also
be presented at CHW in-service days as well as for
various community organizations in the Area Health





ACT: Acceptance and Commitment Therapy; ADIS-IV: Anxiety Disorders
Interview Schedule for DSM-IV; AFQ-Y: Avoidance and Fusion Questionnaire -
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